Impact Biomedical IBO

Impact Biomedical Inc. · NYSE · Pharmaceutical Preparations

$6.17+25.66%close on Nov. 17, 2026 · volume 25K · Yahoo Finance

Price, last 61 sessions

$4.00$6.00Sept. 2026Oct. 2026Nov. 2026
Aug. 24, 2026 to Nov. 17, 2026 · high $7.47 · low $2.68 · SEC filing, placed when SEC released it

Our coverage

Insider buying and selling

DateInsiderTradeSharesAvg. priceValue
Sept. 24, 2026DSS Inc.
10% owner
Sold156$7.06$1,101
Sept. 23, 2026DSS Inc.
10% owner
Sold27$6.95$188
Sept. 22, 2026DSS Inc.
10% owner
Sold723$0.55$398

Open-market purchases and sales reported on SEC Form 4 filed since July 24, 2026; grants, option exercises and shares withheld for tax aren't shown. A trade under a 10b5-1 plan was scheduled in advance. Where a filing was amended, the amendment's figures are shown.

Recent SEC filings

All 21 →
  • 8-KNov. 18, 2026, 10:06 a.m. ETView on SEC.govOur explainer

    Completion of acquisition or disposition of assets · Delisting notice / failure to meet listing standard · Material modification of security holders' rights · Change in control · Departure/appointment of directors or officers · Amendments to articles or bylaws; fiscal year change · Financial statements and exhibits

    AI summary, unreviewedImpact BioMedical Inc. completes reverse merger into Cayman-incorporated PubCo, delists from NYSE American, and shareholders are left with a 4.80% stake

  • 8-KNov. 17, 2026, 4:05 p.m. ETView on SEC.gov

    Submission of matters to a vote of security holders

    AI summary, unreviewedImpact Biomedical Inc. stockholders approve Zoar merger agreement and director slate at November 13, 2026 special meeting

  • 10-QNov. 9, 2026, 4:50 p.m. ETView on SEC.gov
  • 4Nov. 5, 2026, 5:56 p.m. ETView on SEC.gov
  • 4Nov. 5, 2026, 5:55 p.m. ETView on SEC.gov
  • 4Nov. 5, 2026, 5:54 p.m. ETView on SEC.gov
  • 4Nov. 5, 2026, 5:53 p.m. ETView on SEC.gov
  • 4Nov. 5, 2026, 5:51 p.m. ETView on SEC.gov